Plus Therapeutics holds annual meeting post 1-for-25 reverse split; all proposals pass

PLUS THERAPEUTICS, INC.

All six directors elected; votes for ranged from 11.9M to 12.4M; broker non-votes ~50.8M.
Ratification of CBIZ CPAs as auditor for 2026 approved with 60.9M in favor.
Advisory say-on-pay approved with 10.4M for, 3.4M against.
Sixth amendment to 2020 Stock Incentive Plan approved (7.98M for, 5.65M against).
Meeting held after 1-for-25 reverse split effective April 2, 2026; vote results on pre-split share count.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.